Common Stock, Shares, Outstanding of Odyssey Health, Inc. from 31 Jul 2014 to 31 Jan 2026

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Odyssey Health, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Jul 2014 to 31 Jan 2026.
  • Odyssey Health, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Jan 2026 was 99,853,763, a 3.3% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Odyssey Health, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 99,853,763 +3,144,000 +3.3% 31 Jan 2026 10-Q 12 Mar 2026 2026 Q2
Q3 2025 99,853,763 +3,144,000 +3.3% 31 Oct 2025 10-Q 11 Dec 2025 2026 Q1
Q2 2025 96,709,763 0 0% 31 Jul 2025 10-Q 12 Mar 2026 2026 Q2
Q1 2025 96,709,763 +350,000 +0.36% 30 Apr 2025 10-Q 13 Jun 2025 2025 Q3
Q4 2024 96,709,763 +2,276,713 +2.4% 31 Jan 2025 10-Q 14 Mar 2025 2025 Q2
Q3 2024 96,709,763 +14,975,702 +18% 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q2 2024 96,709,763 +17,641,884 +22% 31 Jul 2024 10-K 29 Oct 2025 2025 FY
Q1 2024 96,359,763 +18,251,884 +23% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q3
Q4 2023 94,433,050 +18,625,171 +25% 31 Jan 2024 10-Q 22 Mar 2024 2024 Q2
Q3 2023 81,734,061 +9,739,907 +14% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q1
Q2 2023 79,067,879 +1,207,316 +1.6% 31 Jul 2023 10-K 13 Nov 2024 2024 FY
Q1 2023 78,107,879 -4,768,993 -5.8% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q3
Q4 2022 75,807,879 -6,898,193 -8.3% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q2
Q3 2022 71,994,154 -19,021,496 -21% 31 Oct 2022 10-Q 14 Dec 2022 2023 Q1
Q2 2022 77,860,563 -9,330,605 -11% 31 Jul 2022 10-K 30 Oct 2023 2023 FY
Q1 2022 82,876,872 -18,662,233 -18% 30 Apr 2022 10-Q 14 Jun 2022 2022 Q3
Q4 2021 82,706,072 -8,904,130 -9.7% 31 Jan 2022 10-Q 15 Mar 2022 2022 Q2
Q3 2021 91,015,650 +445,448 +0.49% 31 Oct 2021 10-Q 10 Dec 2021 2022 Q1
Q2 2021 87,191,168 -1,368,810 -1.5% 31 Jul 2021 10-K 31 Oct 2022 2022 FY
Q1 2021 101,539,105 +14,348,705 +16% 30 Apr 2021 10-Q 21 Jun 2021 2021 Q3
Q4 2020 91,610,202 +4,419,802 +5.1% 31 Jan 2021 10-Q 11 Mar 2021 2021 Q2
Q3 2020 90,570,202 +3,579,802 +4.1% 31 Oct 2020 10-Q 11 Dec 2020 2020 Q1
Q2 2020 88,559,978 +1,569,578 +1.8% 31 Jul 2020 10-K 29 Oct 2021 2021 FY
Q1 2020 87,190,400 +18,445,000 +27% 30 Apr 2020 10-Q/A 13 Nov 2020 2020 Q3
Q4 2019 87,190,400 +18,545,000 +27% 31 Jan 2020 10-Q/A 13 Nov 2020 2020 Q2
Q3 2019 86,990,400 +25,576,400 +42% 31 Oct 2019 10-Q/A 13 Nov 2020 2020 Q1
Q2 2019 86,990,400 +25,576,400 +42% 31 Jul 2019 10-K 16 Nov 2020 2021 FY
Q1 2019 68,745,400 -51,094,200 -43% 30 Apr 2019 10-Q 07 Jun 2019 2019 Q3
Q4 2018 68,645,400 -51,194,200 -43% 31 Jan 2019 10-Q 14 Mar 2019 2019 Q2
Q3 2018 61,414,000 -53,425,600 -47% 31 Oct 2018 10-Q 13 Mar 2019 2019 Q1
Q2 2018 61,414,000 -53,336,000 -46% 31 Jul 2018 10-K/A 13 Nov 2020 2019 FY
Q1 2018 119,839,600 +5,000,000 +4.4% 30 Apr 2018 10-Q 07 Aug 2018 2018 Q3
Q4 2017 119,839,600 +5,000,000 +4.4% 31 Jan 2018 10-Q 30 May 2018 2018 Q2
Q3 2017 114,839,600 +89,600 +0.08% 31 Oct 2017 10-Q 20 Dec 2017 2018 Q1
Q2 2017 114,750,000 0 0% 31 Jul 2017 10-K 12 Dec 2018 2018 FY
Q1 2017 114,839,600 +89,600 +0.08% 30 Apr 2017 10-Q 21 Jun 2017 2017 Q3
Q4 2016 114,839,600 +89,600 +0.08% 31 Jan 2017 10-Q 23 Mar 2017 2017 Q2
Q3 2016 114,750,000 0 0% 31 Oct 2016 10-Q 20 Dec 2016 2017 Q1
Q2 2016 114,750,000 0 0% 31 Jul 2016 10-K 14 Nov 2017 2017 FY
Q1 2016 114,750,000 30 Apr 2016 10-Q 16 Jun 2016 2016 Q3
Q4 2015 114,750,000 31 Jan 2016 10-Q 15 Mar 2016 2016 Q2
Q3 2015 114,750,000 31 Oct 2015 10-Q 22 Dec 2015 2016 Q1
Q2 2015 114,750,000 0 0% 31 Jul 2015 10-K 02 Nov 2016 2016 FY
Q2 2014 114,750,000 31 Jul 2014 10-K 01 Dec 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.